Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

Background: Most of the patients with Pancreatic Ductal Adenocarcinoma (PDA) are not eligible for a curative surgical resection. For this reason there is an urgent need for personalized therapies. PDA is the result of complex interactions between tumor molecular profile and metabolites produced by i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Follia, Laura, Ferrero, Giulio, Mandili, Giorgia, Beccuti, Marco, Giordano, Daniele, Spadi, Rosella, Satolli, Maria Antonietta, Evangelista, Andrea, Katayama, Hiroyuki, Hong, Wang, Momin, Amin A., Capello, Michela, Hanash, Samir M., Novelli, Francesco, Cordero, Francesca
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400843/
https://ncbi.nlm.nih.gov/pubmed/30873387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados